Does not enterprise consider traditional Chinese medicine worth doing?

Does not enterprise consider traditional Chinese medicine worth doing?
Staff reporter Xue " watch great limit for 2011 year arrive, see one the intersection of traditional Chinese medicine and export enterprise apply simple and easy to register while being original, such a consequence is that traditional Chinese medicine will have no chance to come into European Union in the capacity of medicines. " The medical health product Deputy Chairman of chamber of import and export trade, traditional Chinese medicine department director Liu ZhangLin of China who says this sentence seems very anxious. According to the traditional medicine law which European Union issued in 2004, all traditional medicines sold in Europe must be with " medicines " registering 2011 years later Appear. " traditional plant medicine registered the procedure order " in Europe in March of 2004 ' Hereafter referred to as " order ") Through after,mean whether because whether it is of our country accord with so long as Chinese herbal medicine by termses relevant, can't can enter by European Union market in the capacity of medicines. Should say, this regulation is that traditional Chinese medicine " becomes a full member " Chance,China medical urge enterprises domestic not to be considered not lasting regulationing from 2004 health product chamber of import and export trade. "In 2004, we were still relatively optimistic, it will interested to think to always have some enterprises, but it is such a situation not to think of. " Liu ZhangLin says. " high threshold " Nearly shut the door It was the application which European Union puts forward that simplified and registered the procedure " The high threshold " Let the export enterprise of traditional Chinese medicine hang back, want to stride this and seem to be the open door but look at the moon in water. " order " requires all medicines listing in application to use the record for 30 years, among them it must be that a certain country uses in Europe in 15 years, and there must be documentary evidences these 30 years, identification substantially as coming from textbook or medical practitioner. "It is got that the enterprises of our country of these materials are impossible, use in Europe of Chinese herbal medicine is all on the non-mainstream market, very great in the folk difficulty of collecting the data. Costs just 7 years altogether from 2004 to 2011, how could are there data in 15 years? " Liu ZhangLin thinks the biggest bottleneck required to register through being simple and easy of service life. So, this association of dealers has been already consulting with relevant department of Europe, has hoped to " close the door " Time limit can lengthen by 2019,in this way collect data are just 15 year by 2019 since 2004 Chinese enterprise. But up till now, European Union has not expressed that lengthen time limit. The whole Europe traditional Chinese medicine learns Dong ZhiLin, president of federation, how to introduce, there are 20 traditional medicines that Europe gets permission to register at present, raw materials all come from the countries besides Europe, among them Japan has registered 12 flavor traditional Chinese medicine, compound red red-spotted stonecrop comes from countries such as Russia, Mongolia,etc.. He thinks, it is that our country has not passed the enterprises of European Union GMP examination and approval that domestic traditional Chinese medicine enterprises export the so passive reason, apply necessary fund far higher than can be the income that enterprises bring criticize, perhaps, enterprises are unwilling to participate in in reason too. Cater to the standard and strive for acknowledging one side is the reality that Chinese herbal medicine cures the sickness to save the patient through the ages, one side is almost harsh and high-standard in Europe, only both sides agree with, traditional Chinese medicine could go abroad smoothly. Grandfather's mere professor of leaf of academy of sciences of China's Chinese medicine thinks, GMP of Europe is not as terrible as what was imagined in domestic enterprises, but in domestic detail and marrow of European GMP that nobody really understands, what they paid attention to is often ignored by us. In fact the working conditions and software and hardware levels of a lot of domestic enterprises have already exceeded a lot of overseas enterprises authorized through European GMP. He proposes, the government department of our country should emphasize our attention to the security of medicines more while communicating with European authorities, hope these countries can admit GMP of our country, import Chinese herbal medicine through the enterprises of GMP of our country, so can reduce the huge cost that enterprises GMP transformed. "Even if strive for 8 years more, will be there enterprises that apply? How having entered? " Professor Tu PengFei of College of Pharmacy of Peking University thinks, " order " is met coldly in the traditional Chinese medicine enterprises of our country, it is a bottleneck of the time limit that the surface is seen, deeper question is that we can't enter medical market of mainstream and medical insurance system of Europe, determine even if Chinese herbal medicine enters Europe, export quantum is extremely limited in this way. And traditional Chinese medicine is various in style, how much each kind of medicine can not sold, but will all pass the complicated application procedure, put into and produce and far from letting enterprises make profits. The expert points out, if whether these products have already been listed in European Union plant's medicine list or plant medicine monograph, can also be according to simplifying the procedure to register correspondingly. More experts think whether should make traditional Chinese medicine more competitive in the world, or should participate in the foreign and officinal modification more positively, introduce traditional Chinese medicine into the medical market of mainstream of Europe progressively. It is reported, Chinese medicinal materials enter France's officinal work and are in progress.

|